NCT05461716 - Incidence of Hypoglycaemia Events in Patients With Stable Insulin-treated Type 2 Diabetes Mellitus Based on Continuous Glucose Monitoring | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

March 31, 2023

Conditions

Diabetes Mellitus Type 2 With Hypoglycemia

Interventions

DEVICE

periodic use of Continuous Glucose Monitoring (CGM)

Identification of hypoglycaemia events, based on use of Continuous Glucose Monitoring (CGM) for at least 14days, in subgroups of T2DM patients with high risk of hypoglycaemia

Trial Locations (1)

41110

RECRUITING

Department of Endocrinology and Metabolic Diseases, University Hospital of Larisa, Larissa